BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 25698590)

  • 21. Recent progress in the diagnosis and treatment of primary vitreoretinal lymphoma.
    Zhou M; Xu G
    Taiwan J Ophthalmol; 2016; 6(4):170-176. PubMed ID: 29018736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary vitreoretinal lymphoma: prevalence, impact, and management challenges.
    Venkatesh R; Bavaharan B; Mahendradas P; Yadav NK
    Clin Ophthalmol; 2019; 13():353-364. PubMed ID: 30858685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis, Risk Factors, and Clinical Features of Intraocular Recurrence in Primary Vitreoretinal Lymphoma.
    Liu S; Jiang T; Gu J; Zhou X; Chen W; Ping B; Zhou Y; Zhang T; Huang X; Xu G; Chang Q
    Ophthalmol Retina; 2024 Apr; 8(4):317-324. PubMed ID: 37918656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.
    Kaburaki T; Taoka K
    Jpn J Ophthalmol; 2023 Jul; 67(4):363-381. PubMed ID: 37209195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary intraocular lymphoma.
    Sagoo MS; Mehta H; Swampillai AJ; Cohen VM; Amin SZ; Plowman PN; Lightman S
    Surv Ophthalmol; 2014; 59(5):503-16. PubMed ID: 24560125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An unusual case report of primary vitreoretinal lymphoma.
    Tan SZ; Steeples LR; Chhabra R; Jones NP
    BMC Ophthalmol; 2018 Sep; 18(Suppl 1):223. PubMed ID: 30255824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical review: treatment of vitreoretinal lymphoma.
    Pe'er J; Hochberg FH; Foster CS
    Ocul Immunol Inflamm; 2009; 17(5):299-306. PubMed ID: 19831557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential.
    Yonese I; Takase H; Yoshimori M; Onozawa E; Tsuzura A; Miki T; Mochizuki M; Miura O; Arai A
    Eur J Haematol; 2019 Feb; 102(2):191-196. PubMed ID: 30390359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Research progress in the diagnosis of primary vitreoretinal lymphoma].
    Tuo YR; Zhang MF
    Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):954-959. PubMed ID: 37936364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A diagnostic challenge of primary Central nervous system lymphoma: from the eyes to the brain.
    Su M; Huang D; Sun L; Dong Z; Wu L; Yu S
    Int J Neurosci; 2021 Nov; 131(11):1139-1145. PubMed ID: 32449877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Primary vitreoretinal lymphoma].
    Jaehne D; Coupland SE
    Ophthalmologe; 2018 Apr; 115(4):343-356. PubMed ID: 29589147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.
    Riemens A; Bromberg J; Touitou V; Sobolewska B; Missotten T; Baarsma S; Hoyng C; Cordero-Coma M; Tomkins-Netzer O; Rozalski A; Tugal-Tutkun I; Guex-Crosier Y; Los LI; Bollemeijer JG; Nolan A; Pawade J; Willermain F; Bodaghi B; ten Dam-van Loon N; Dick A; Zierhut M; Lightman S; Mackensen F; Moulin A; Erckens R; Wensing B; le Hoang P; Lokhorst H; Rothova A
    JAMA Ophthalmol; 2015 Feb; 133(2):191-7. PubMed ID: 25412269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma.
    Anthony CL; Bavinger JC; Shantha JG; O'Keefe GD; Pearce WA; Voloschin A; Grossniklaus HE; Yeh S
    Int J Retina Vitreous; 2021 Dec; 7(1):72. PubMed ID: 34863313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refractory Primary Vitreoretinal Lymphoma Involving the Spinal Cord with a Temporary Complete Response to Tirabrutinib.
    Iizuka-Honma H; Takizawa H; Mitsumori T; Okura H; Ishii H; Noguchi M
    Intern Med; 2023 Feb; 62(3):459-463. PubMed ID: 35793963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma.
    Hashida N; Nakai K; Saitoh N; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):687-93. PubMed ID: 24549401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma.
    Wang Y; Shen D; Wang VM; Sen HN; Chan CC
    Int J Mol Sci; 2011; 12(9):5684-97. PubMed ID: 22016619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DEVELOPMENT OF EPSTEIN-BARR VIRUS UVEITIS AFTER REMISSION OF PRIMARY VITREORETINAL LYMPHOMA.
    Chahal BS; Rasmussen S; White VA; Forooghian F
    Retin Cases Brief Rep; 2016; 10(2):131-3. PubMed ID: 26267526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis.
    Touhami S; Audo I; Terrada C; Gaudric A; LeHoang P; Touitou V; Bodaghi B
    Prog Retin Eye Res; 2019 Sep; 72():100761. PubMed ID: 31091471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral radiation therapy followed by methotrexate-based chemotherapy for primary vitreoretinal lymphoma.
    de la Fuente MI; Alderuccio JP; Reis IM; Omuro A; Markoe A; Echegaray JJ; Davis JL; Harbour JW; Lossos IS
    Am J Hematol; 2019 Apr; 94(4):455-460. PubMed ID: 30663807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid Resolution of Presumed Vitreoretinal Lymphoma With Systemic Ibrutinib Therapy.
    Mathai M; Fein JG
    Ophthalmic Surg Lasers Imaging Retina; 2021 Apr; 52(4):227-230. PubMed ID: 34039188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.